Novavax Inc (NVAX) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.29x

Novavax Inc (NVAX) has a Cash Flow Reinvestment Rate of 1.29x as of September 2025, reinvesting $138.55 Million (capex $2.02 Million plus investments $-136.53 Million) from operating cash flow of $107.80 Million. Explore how much does Novavax Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.29x
(Capex + Investments) / Operating CF

Total Reinvested

$138.55 Million
Capex + Investments

Operating Cash Flow

$107.80 Million
USD

Capital Expenditures

$2.02 Million
USD

Novavax Inc Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for Novavax Inc across 1 annual periods. Also explore Novavax Inc total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Novavax Inc (2021–2021)

Year-by-year capital reinvestment analysis for Novavax Inc. For live market cap and broader valuation context, see Novavax Inc market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 0.67x $215.13 Million $322.95 Million $57.49 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow